Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.91)
# 713
Out of 5,044 analysts
465
Total ratings
45.71%
Success rate
11.93%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IPHA Innate Pharma | Upgrades: Buy | $5 | $2.09 | +139.41% | 18 | Oct 29, 2025 | |
| UNCY Unicycive Therapeutics | Maintains: Buy | $9 → $22 | $4.94 | +345.34% | 2 | Oct 29, 2025 | |
| DYAI Dyadic International | Assumes: Buy | $3 | $1.10 | +172.73% | 1 | Oct 23, 2025 | |
| CELC Celcuity | Maintains: Buy | $66 → $77 | $72.30 | +6.50% | 10 | Oct 22, 2025 | |
| DCTH Delcath Systems | Maintains: Buy | $31 → $30 | $9.95 | +201.51% | 15 | Oct 20, 2025 | |
| CORT Corcept Therapeutics | Reiterates: Buy | $145 | $72.29 | +100.58% | 24 | Oct 20, 2025 | |
| EVAX Evaxion | Reiterates: Buy | $16 | $6.11 | +161.87% | 14 | Oct 20, 2025 | |
| ACTU Actuate Therapeutics | Reiterates: Buy | $20 | $6.69 | +198.95% | 3 | Sep 23, 2025 | |
| DNTH Dianthus Therapeutics | Reiterates: Buy | $40 | $33.32 | +20.05% | 7 | Sep 8, 2025 | |
| PSNL Personalis | Reiterates: Buy | $8.5 | $9.89 | -14.05% | 17 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $2.24 | +392.17% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $4.06 | +109.62% | 13 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $3.41 | +46.63% | 10 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $15 | $5.21 | +187.91% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $25.20 | +138.10% | 14 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $3.5 | $3.83 | -8.50% | 17 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.76 | +70.94% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $80 | $71.59 | +11.75% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $130 | $102.49 | +26.85% | 4 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.53 | +357.52% | 22 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $35 | $18.66 | +87.57% | 8 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $31 | $18.16 | +70.70% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $2.19 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.08 | +177.78% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $1.59 | +25.79% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $60 | $5.31 | +1,029.94% | 15 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $2.17 | +61.29% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $2.21 | +759.73% | 14 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.49 | - | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $4.42 | +58.37% | 14 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $180 | $2.04 | +8,722.66% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $5.10 | +390.20% | 13 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $0.66 | +1,858.72% | 7 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $28.65 | +144.33% | 12 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $36.77 | +63.18% | 18 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $8.67 | +280.62% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.27 | +1,751.85% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.40 | - | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.29 | +50.89% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.02 | +562.25% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.72 | +57.34% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.71 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.52 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.61 | +459.01% | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.93 | +1,195.61% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.83 | +173.97% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $3.43 | +3,398.54% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $1.59 | +654.72% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.70 | +2,767.38% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $17.50 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $7.79 | -22.98% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $1.84 | +715.22% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $8.64 | +282.17% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $17.03 | -44.22% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $1.50 | +933,233.33% | 1 | Mar 5, 2020 |
Innate Pharma
Oct 29, 2025
Upgrades: Buy
Price Target: $5
Current: $2.09
Upside: +139.41%
Unicycive Therapeutics
Oct 29, 2025
Maintains: Buy
Price Target: $9 → $22
Current: $4.94
Upside: +345.34%
Dyadic International
Oct 23, 2025
Assumes: Buy
Price Target: $3
Current: $1.10
Upside: +172.73%
Celcuity
Oct 22, 2025
Maintains: Buy
Price Target: $66 → $77
Current: $72.30
Upside: +6.50%
Delcath Systems
Oct 20, 2025
Maintains: Buy
Price Target: $31 → $30
Current: $9.95
Upside: +201.51%
Corcept Therapeutics
Oct 20, 2025
Reiterates: Buy
Price Target: $145
Current: $72.29
Upside: +100.58%
Evaxion
Oct 20, 2025
Reiterates: Buy
Price Target: $16
Current: $6.11
Upside: +161.87%
Actuate Therapeutics
Sep 23, 2025
Reiterates: Buy
Price Target: $20
Current: $6.69
Upside: +198.95%
Dianthus Therapeutics
Sep 8, 2025
Reiterates: Buy
Price Target: $40
Current: $33.32
Upside: +20.05%
Personalis
Sep 8, 2025
Reiterates: Buy
Price Target: $8.5
Current: $9.89
Upside: -14.05%
Aug 21, 2025
Reiterates: Buy
Price Target: $11
Current: $2.24
Upside: +392.17%
Aug 19, 2025
Reiterates: Buy
Price Target: $8.5
Current: $4.06
Upside: +109.62%
Aug 19, 2025
Reiterates: Buy
Price Target: $5
Current: $3.41
Upside: +46.63%
Aug 14, 2025
Reiterates: Neutral
Price Target: $15
Current: $5.21
Upside: +187.91%
Aug 14, 2025
Reiterates: Buy
Price Target: $60
Current: $25.20
Upside: +138.10%
Aug 13, 2025
Maintains: Buy
Price Target: $7 → $3.5
Current: $3.83
Upside: -8.50%
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.76
Upside: +70.94%
Aug 7, 2025
Maintains: Buy
Price Target: $73 → $80
Current: $71.59
Upside: +11.75%
Jun 24, 2025
Maintains: Buy
Price Target: $110 → $130
Current: $102.49
Upside: +26.85%
Jun 24, 2025
Reiterates: Buy
Price Target: $7
Current: $1.53
Upside: +357.52%
May 29, 2025
Maintains: Buy
Price Target: $33 → $35
Current: $18.66
Upside: +87.57%
May 22, 2025
Maintains: Buy
Price Target: $25 → $31
Current: $18.16
Upside: +70.70%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $2.19
Upside: -
May 19, 2025
Reiterates: Buy
Price Target: $3
Current: $1.08
Upside: +177.78%
May 9, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $1.59
Upside: +25.79%
May 6, 2025
Maintains: Buy
Price Target: $135 → $60
Current: $5.31
Upside: +1,029.94%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $2.17
Upside: +61.29%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $2.21
Upside: +759.73%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.49
Upside: -
Mar 19, 2025
Reiterates: Buy
Price Target: $7
Current: $4.42
Upside: +58.37%
Mar 14, 2025
Maintains: Buy
Price Target: $240 → $180
Current: $2.04
Upside: +8,722.66%
Mar 13, 2025
Reiterates: Buy
Price Target: $25
Current: $5.10
Upside: +390.20%
Mar 11, 2025
Reiterates: Buy
Price Target: $13
Current: $0.66
Upside: +1,858.72%
Mar 3, 2025
Reiterates: Buy
Price Target: $70
Current: $28.65
Upside: +144.33%
Feb 28, 2025
Reiterates: Buy
Price Target: $60
Current: $36.77
Upside: +63.18%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $8.67
Upside: +280.62%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $0.27
Upside: +1,751.85%
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $9.40
Upside: -
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $7.29
Upside: +50.89%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $3.02
Upside: +562.25%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $5.72
Upside: +57.34%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.71
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.52
Upside: -
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $1.61
Upside: +459.01%
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.93
Upside: +1,195.61%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $1.83
Upside: +173.97%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $3.43
Upside: +3,398.54%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $1.59
Upside: +654.72%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.70
Upside: +2,767.38%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $17.50
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $7.79
Upside: -22.98%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $1.84
Upside: +715.22%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $8.64
Upside: +282.17%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $17.03
Upside: -44.22%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $1.50
Upside: +933,233.33%